Evidence map›Paper›PMID 36465275›Full record

ArticleInternational journal of pharmaceutics: X2022

Long term behavior of dexamethasone-loaded cochlear implants: In vitro & in vivo.

T Rongthong, A Qnouch, M Maue Gehrke, F Danede, J F Willart, P F M de Oliveira, L Paccou, G Tourrel, P Stahl, J Verin and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Frontiers in bioengineering and biotechnology · 2026
    Article
  2. Article
  3. EVA implants for controlled drug delivery to the inner ear.International journal of pharmaceutics: X · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

T RongthongUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
A QnouchUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
M Maue GehrkeUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
F DanedeUniv. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France.
J F WillartUniv. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France.
P F M de OliveiraUniv. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France.
L PaccouUniv. Lille, UMR CNRS 8207, UMET, F-59655 Villeneuve d'Ascq, France.
G TourrelOticon Medical, R&D, 06224 Vallauris, France.
P StahlOticon Medical, R&D, 06224 Vallauris, France.
J VerinUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
P ToulemondeUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
C VincentUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
F SiepmannUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
J SiepmannUniv. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.
Inserm · FRUniversité de Lille · FRCentre Hospitalier Universitaire de Lille · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to better understand the long term behavior of silicone-based cochlear implants loaded with dexamethasone: in vitro as well as in vivo (gerbils). This type of local controlled drug delivery systems offers an interesting potential for the treatment of hearing loss. Because very long release periods are targeted (several years/decades), product optimization is highly challenging. Up to now, only little is known on the

Indexed as

Cochlear implantDexamethasoneDiffusionRaman imagingSilicone

Identifiers

PMID36465275
PMCPMC9713292
OpenAlexW4309768769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.